This article is more than 5 years old. Information may no longer be current.

Visionary Venture Fund and Advisory Board to support ophthalmology startups

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

OCTANe, a business development accelerator, has launched the Visionary Venture Fund and Advisory Board to assist later-stage ophthalmology startup companies, according to a press release.

OCTANe established a $50 million venture fund to assist select startup companies that are developing promising technology. In addition, more than 20 leaders in the ophthalmology industry will be available to provide guidance on development, initial funding and commercialization.

“This is a unique opportunity to create an inflection point in the development of groundbreaking research and technology development in the ophthalmology field,” Bill Carpou, president and CEO of OCTANe, said in the release. “These leaders provide the insight to identify innovative trends and, when combined with the OCTANe LaunchPad process and advisor network, a greater level of support for startup success.”